ST. LOUIS FORENSIC TREATMENT CENTER
1. Target Overview & Investment Thesis
ST. LOUIS FORENSIC TREATMENT CENTER is a 255-bed under-performing / distressed in nan, MO with $45.0M in net patient revenue and a -81.9% operating margin. The hospital serves a payer mix of 0.1% Medicare, 3.2% Medicaid, and 96.6% commercial.
Thesis: Undervalued. Our ML models identify $3.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -81.9% to -74.5% (+736bps).
| Net Revenue HCRIS | $45.0M |
| Current EBITDA COMPUTED | $-36.9M |
| Operating Margin COMPUTED | -81.9% |
| Occupancy HCRIS | 93.8% |
| Revenue / Bed COMPUTED | $177K |
| Net-to-Gross HCRIS | 65.5% |
| Distress Probability ML | 42.6% |
2. Market Context & Competitive Position
MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -81.9% places it below the state median. Among 34 size-comparable peers (128-510 beds), the median margin is -2.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (128-510), prioritizing same-state peers. 34 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ST. LOUIS FORENSIC TREATMENT C (Target) | MO | 255 | $45.0M | -81.9% |
| CHILDRENS MERCY HOSPITAL | MO | 328 | $1.44B | 30.5% |
| ST. LOUIS CHILDRENS HOSPITAL | MO | 445 | $886.1M | 6.4% |
| SAINT LUKES HOSPITAL OF KANSAS | MO | 466 | $883.5M | -12.4% |
| SSM HEALTH ST. MARYS HOSPITAL | MO | 501 | $792.8M | -0.0% |
| SSM SAINT LOUIS UNIVERSITY HOS | MO | 317 | $772.2M | -6.4% |
| MISSOURI BAPTIST MEDICAL CENTE | MO | 402 | $716.0M | 2.5% |
| HEARTLAND REGIONAL MEDICAL CEN | MO | 352 | $676.9M | -6.2% |
| NORTH KANSAS CITY HOSPITAL | MO | 383 | $601.5M | 7.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $946K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $901K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $892K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $548K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $29K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-36.9M |
| + RCM Uplift | +$3.3M |
| Pro Forma EBITDA | $-33.6M |
| Current Margin | -81.9% |
| Pro Forma Margin | -74.5% |
| WC Released (1x) | $1.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-56.8M | $-210.2M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-56.8M | $-249.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-51.1M | $-257.1M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-51.1M | $-295.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-62.4M | $-208.3M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-62.4M | $-249.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 34 hospitals with 128-510 beds
- Same-state prioritization (n=35)
- Comp margins: P25=-12.2% / P50=-2.2% / P75=4.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.